Graft Failure and Consequences of Coronary Artery Bypass Graft Surgery

Recruiting Observational Study
Coronary Artery Bypass Graft Failure Coronary Artery Bypass Graft Coronary Artery Bypass Graft Surgery (CABG)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
70 (estimated)
Sponsor
University of Edinburgh · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Coronary artery bypass graft (CABG) surgery is the commonest type of heart operation performed. During this, arteries or veins (termed 'grafts') are used to supply blood around blockages within the blood vessels that supply the heart. Unfortunately, these grafts can sometimes fail, and patients can also experience complications like heart attacks and strokes, after surgery. It is known that vein g…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
INCLUSION CRITERIA: Cohort 1: Patients undergoing CABG surgery * Males and females over 18 years of age * Patients undergoing CABG surgery for multivessel coronary artery disease, who receive at least one saphenous vein graft Cohort 2: Patients with symptomatic saphenous vein graft vasculopathy …
Contacts

Laura E Clark, BSc, MBChB, MRCS(Ed)

+447717478087

lclark15@ed.ac.uk

CONTACT

David E Newby, BSc (Hons) PhD BM DM DSc FRCP

d.e.newby@ed.ac.uk

CONTACT